Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Grant/Award of 24,122 PHAT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 24,122 | n/a |
| Sep 30, 2025 | MBX Biosciences, Inc. (MBX) | Purchase | 666,666 | $12.00M |
| Sep 17, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Purchase | 660 | $15.6K |
| Sep 10, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Purchase | 1,260 | $31.5K |
| Aug 13, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Purchase | 471 | $11.3K |
| Jun 26, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Purchase | 2,520 | $46.5K |
| Jun 18, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Purchase | 8,584 | $167.4K |
| Jun 5, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 10,500 | n/a |
| May 23, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Purchase | 3,780 | $14.6K |
| May 15, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Purchase | 1,120 | $3.5K |